Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsTissue DonorsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationWhole-Body IrradiationBone and BonesHistocompatibility TestingAnemia, AplasticTransplantation ConditioningLiver TransplantationLeukemiaTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicCyclophosphamideKidney TransplantationDonor SelectionBone Marrow DiseasesGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationHematopoiesisRecurrenceT-LymphocytesCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationGraft RejectionSpleenImmunosuppressive AgentsTreatment OutcomeHematologic NeoplasmsRemission InductionTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsLeukemia, MyeloidImmunosuppressionLeukocyte TransfusionLymphocyte DepletionHeart TransplantationStem Cell TransplantationAcute DiseaseLymphoma, Non-HodgkinCells, CulturedSevere Combined ImmunodeficiencyHLA AntigensChimeraColony-Forming Units AssaySurvival AnalysisRetrospective StudiesLymphocytesMyelodysplastic SyndromesLung TransplantationCyclosporineActuarial AnalysisHematologic DiseasesBlood DonorsBone DensityLymphocyte TransfusionOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaFollow-Up StudiesSurvival RateCytomegalovirus InfectionsLeukocyte CountGraft vs Leukemia EffectCytarabineMice, Inbred BALB CBone ResorptionMelphalanDisease-Free SurvivalFlow CytometryEtoposideLymphomaMultiple MyelomaFatal OutcomeAntigens, CD34Mice, KnockoutCell Transplantation